Company / EPS (Basic)
KIORA PHARMACEUTICALS INC EPS (Basic) History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Basic)
$0.93
FY2025
5-year range
-$24.25 / $0.93
FY2021-FY2025
Trend
+103.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $-1.77 to $0.93 over the past 4 years.
Based on SEC 10-K filings.
0.93 in FY2025.
Improved from $-1.77 to $0.93 over the past 4 years.
EPS (Basic) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, eps (basic) increased 103.8% year-over-year.
Company context
Key Data Points
- Altman Z-Score -5.41 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Basic)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.93 | +103.8% |
| FY2024 | -$24.25 | -1270.1% |
| FY2021 | -$1.77 | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026